Expert Opinion on Pharmacotherapy

Sirolimus- or paclitaxel-eluting stents to prevent coronary artery restenosis
pp. 2209-2220(12)
Author: Sheila A Doggrell

Vascular restenosis – striving for therapy
pp. 2221-2232(12)
Authors: Thomas M Schiele; Florian Krötz; Volker Klauss

Recent progress in the therapeutic management of pre-eclampsia
pp. 2233-2239(7)
Authors: Delia Maria Paternoster; Sara Fantinato; Francesca Manganelli; Umberto Nicolini; Massimo Milani; Antonio Girolami

New phosphodiesterase inhibitors in the treatment of erectile dysfunction
pp. 2241-2249(9)
Authors: Paul CB Anderson; Lyndon Gommersall; Dickon Hayne; Manit Arya; Hitendra RH Patel

Current pharmacological treatment of gastroparesis
pp. 2251-2254(4)
Authors: Y Vandenplas; B Hauser; S Salvatore

Pharmacological treatment of nephropathic cystinosis with cysteamine
pp. 2255-2262(8)
Authors: Robert Kleta; William A Gahl

Lupus nephritis: a review of the current pharmacological treatments
pp. 2263-2277(15)
Authors: Lucile Mercadal; Gilbert Deray

The role of growth hormone-receptor antagonism in relation to acromegaly
pp. 2279-2285(7)
Authors: John Ayuk; Michael C Sheppard

Available pharmacological treatments for anorexia nervosa
pp. 2287-2292(6)
Authors: Pauline S Powers; Carlos Santana

Treatment strategies in controlling strongyloidiasis
pp. 2293-2301(9)
Authors: Masao Satoh; Akatsuki Kokaze

Telmisartan/hydrochlorothiazide combination therapy in the treatment of essential hypertension
pp. 2303-2310(8)
Author: Roland E Schmieder

Losartan for the treatment of hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study
pp. 2311-2320(10)
Authors: Richard B Devereux; Paulette A Lyle

Daptomycin – a novel antibiotic against Gram-positive pathogens
pp. 2321-2331(11)
Authors: Kerry L LaPlante; Michael J Rybak

Review of the use of topotecan in ovarian carcinoma
pp. 2333-2340(8)
Authors: Tanya Ahmad; Martin Gore

Efficacy and safety of ibandronate in the treatment of neoplastic bone disease
pp. 2341-2350(10)
Author: Martin Pecherstorfer

Oxybutynin for treatment of urge urinary incontinence and overactive bladder: an updated review
pp. 2351-2359(9)
Authors: Yoram Abramov; Peter K Sand

Adefovir dipivoxil in chronic hepatitis B infection
pp. 2361-2367(7)
Authors: Man-Fung Yuen; Ching-Lung Lai

Review of tegaserod in the treatment of irritable bowel syndrome
pp. 2369-2379(11)
Authors: Sonal Patel; iss Berrada; Anthony Lembo

Clinical-economic appropriateness of drug treatments: designing a method that combines evidence-based information and cost assessments to construct league tables accounting for the potential number of patients
pp. 2381-2389(9)
Authors: Andrea Messori; Benedetta Santarlasci; Sabrina Trippoli; Monica Vaiani; Franca Vacca; M Chiara Brutti

Therapeutic approaches in treating Creutzfeldt-Jakob disease – what does the future hold?
pp. 2391-2396(6)
Author: Esther A Croes

Telmisartan – killing two birds with one stone
pp. 2397-2400(4)
Author: Sheila A Doggrell